Kevin T. Conroy is President, Chief Executive Officer and Chairman of the Board of Exact Sciences. In 2004, he joined Third Wave Technology where he was the company’s General Counsel. From 2005 to July of 2008, Mr. Conroy served as Third Wave’s President and Chief Executive Officer until their acquisition by Hologic. Prior to joining Third Wave, Conroy served as Intellectual Property counsel at GE Healthcare. Before joining GE Healthcare, Conroy was Chief Operating Officer of two early stage, venture-backed technology companies in Northern California. Prior to those positions, he was an Intellectual Property litigator at two Chicago law firms: McDermott Will & Emery; and Pattishall, McAuliffe, Newbury, Hilliard and Geraldson, where he was a partner. He earned a Bachelor of Science degree in electrical engineering from Michigan State University, as well as a Law degree from the University of Michigan Law School.

Dr. Hanash currently serves as director of the Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer at The University of Texas MD Anderson Cancer Center. In addition, he is Co-Director of MD Anderson's Center for Global Cancer Early Detection, Evelyn & Sol Rubenstein Distinguished Chair for Cancer Prevention, and Professor in the Department of Clinical Cancer Prevention - Research, Division of OVP, Cancer Prevention and Population Sciences. Dr. Hanash has authored dozens of articles published in leading peer-reviewed journals, is a prolific speaker and has received numerous awards and honors, including the Evelyn & Sol Rubenstein Distinguished Chair for Cancer Prevention, the University of Michigan Innovator Award and the Curie Institute Rothschild Award. Dr. Hanash received his BS and MD in Human Genetics from the American University of Beirut in Lebanon and his PhD in Human Genetics from the University of Michigan, Ann Arbor.